In this issue:
Role of interferon-γ in APS-1
Once-daily dexfadrostat phosphate for primary aldosteronism
Lanreotide for tumour reduction in NFPMA
Long-term outcomes for Cushing's disease or NFPA after pituitary surgery
Zoledronate after denosumab discontinuation: repeated vs. single administration
BMD after parathyroidectomy for primary hyperparathyroidism
Diagnostic performance of copeptin in polyuria-polydipsia syndrome
Psychopathology of patients with AVP and primary polydipsia
Longitudinal reproductive endocrine function in Cushing syndrome
Secondary hypogonadism in men with Cushing syndrome/MACS
Please login below to download this issue (PDF)